1983
DOI: 10.1007/bf00417202
|View full text |Cite
|
Sign up to set email alerts
|

Cysteine proteinase inhibitors in psoriatic epidermis

Abstract: Human psoriatic epidermis and scales were demonstrated to contain two antigenically separate cysteine proteinase inhibitors, one acidic with an isoelectric point of 4.7-5.0 (ACPI) and one neutral with an isoelectric point of 6.0-6.5 (NCPI), while normal epidermis contains only ACPI. The total papain (cysteine proteinase) inhibiting activity of the psoriatic epidermis as calculated per mg protein was higher than that in normal epidermis. Both ACPI and NCPI were localized immunocytochemically, mainly in the high… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

1990
1990
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 19 publications
0
11
0
1
Order By: Relevance
“…Some cysteine proteinase inhibitors were isolated from human and rat skins, and characterized [2,3]. One of them, cystatin-cu, which belongs to family 1, has a low molecular weight and has been found in the skin in high levels, especially in the epidermal cells [4].…”
Section: Methodsmentioning
confidence: 99%
“…Some cysteine proteinase inhibitors were isolated from human and rat skins, and characterized [2,3]. One of them, cystatin-cu, which belongs to family 1, has a low molecular weight and has been found in the skin in high levels, especially in the epidermal cells [4].…”
Section: Methodsmentioning
confidence: 99%
“…In addition to the ability to selectively ablate epidermal neoplasms, TPT may also prove useful in the treatment of several non‐neoplastic dermatologic conditions. Support for such applications comes from the previous identification of an endogenous 43 kD papain inhibitor from psoriatic scale 44,45 . This 43 kD papain inhibitor has subsequently been demonstrated in lesions of ichthyosis, eczema, actinic keratosis, verruca, condyloma, molluscum, Bowen's disease, and squamous cell carcinoma, as well as in fetal skin 46,47 .…”
Section: Commentsmentioning
confidence: 99%
“…Support for such applications comes from the previous identification of an endogenous 43 kD papain inhibitor from psoriatic scale. 44,45 This 43 kD papain inhibitor has subsequently been demonstrated in lesions of ichthyosis, eczema, actinic keratosis, verruca, condyloma, molluscum, Bowen's disease, and squamous cell carcinoma, as well as in fetal skin. 46,47 This is further underscored by a recent study that demonstrated defects in endogenous SCCE expression in squamoproliferative disorders such as actinic keratosis, ichthyosis vulgaris, and squamous cell carcinoma in situ.…”
Section: Commentsmentioning
confidence: 99%
“…in several epimeroid carcinomas including squamous cell carcinomata of the lung, skin, vulva, cervix and oesophagus [41,42] but was absent from a variety of other carcinomas [43]. Additionally, the serum level of stefin A has been shown to increase significantly in patients with cardiovascular disease [44] and the inhibitor has been found in the upper spinous layer of psoriatic cells. Stefin A has been found to be a sensitive marker during HIV-1infection and for regeneration of follicular lymphoid tissue [45].…”
Section: Stefin a (Cystatin A Or ˛)mentioning
confidence: 99%